Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
Operating Expenses | 5,424 | 3,106 | 3,036 | 3,873 | 2,557 |
Operating Income | -5,424 | -3,106 | -3,036 | -3,873 | -2,557 |
Interest Expense | 2 | 4 | 2 | 1 | 16 |
Other Income | 0 | 0 | 0 | 4 | 0 |
Pre-tax Income | -5,426 | -3,110 | -3,037 | -3,869 | -2,573 |
Net Income Continuous | -5,426 | -3,110 | -3,037 | -3,869 | -2,573 |
Net Income | $-5,426 | $-3,110 | $-3,037 | $-3,869 | $-2,573 |
EPS Basic Total Ops | -8.30 | -4.80 | -4.50 | -6.00 | -4.50 |
EPS Basic Continuous Ops | -8.28 | -4.79 | -4.67 | -6.82 | -4.10 |
EPS Diluted Total Ops | -8.30 | -4.80 | -4.50 | -6.00 | -4.50 |
EPS Diluted Continuous Ops | -8.28 | -4.79 | -4.67 | -6.82 | -4.10 |
EPS Diluted Before Non-Recurring Items | -9.00 | -4.50 | -4.50 | N/A | N/A |
EBITDA(a) | $-5,418 | $-3,101 | $-3,028 | $-3,873 | $-2,557 |